首页> 美国卫生研究院文献>Human Gene Therapy >Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing
【2h】

Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing

机译:由截短的gRNA指导的二聚体CRISPR RNA引导的FokI-dCas9核酸酶用于高度特异性的基因组编辑

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Monomeric clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated 9 (Cas9) nucleases have been widely adopted for simple and robust targeted genome editing but also have the potential to induce high-frequency off-target mutations. In principle, two orthogonal strategies for reducing off-target cleavage, truncated guide RNAs (tru-gRNAs) and dimerization-dependent RNA-guided FokI-dCas9 nucleases (RFNs), could be combined as tru-RFNs to further improve genome editing specificity. Here we identify a robust tru-RFN architecture that shows high activity in human cancer cell lines and embryonic stem cells. Additionally, we demonstrate that tru-gRNAs reduce the undesirable mutagenic effects of monomeric FokI-dCas9. Tru-RFNs combine the advantages of two orthogonal strategies for improving the specificity of CRISPR/Cas nucleases and therefore provide a highly specific platform for performing genome editing.
机译:单体簇规则间隔的短回文重复序列(CRISPR)/ CRISPR相关的9(Cas9)核酸酶已被广泛用于简单而强大的靶向基因组编辑,但也具有诱导高频脱靶突变的潜力。原则上,可以将两种减少脱靶切割的正交策略,截短的引导RNA(tru-gRNA)和二聚化依赖性的RNA引导的FokI-dCas9核酸酶(RFN)结合起来,作为tru-RFN来进一步提高基因组编辑特异性。在这里,我们确定了一个强大的tru-RFN架构,该架构在人类癌细胞系和胚胎干细胞中显示出高活性。此外,我们证明tru-gRNA减少了单体FokI-dCas9的不良诱变作用。 Tru-RFNs结合了两种正交策略的优势,以提高CRISPR / Cas核酸酶的特异性,因此为执行基因组编辑提供了高度特异性的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号